Trial intelligence / Profile preview

Analgesia for Emergence Agitation in Pediatric ENT Surgery

NCT03062488Phase 1Completed

Sponsor
Nemours Children's Health
Start
Oct 2017
Primary completion
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of acetaminophen in Emergence agitation (EA) and pain (3 arms), sponsored by Nemours Children's Health. Primary endpoint: Emergence Agitation as Measured by Standardized PAED Scale at 60 months. Started Oct 2017; status: completed.

02

Drugs

acetaminophen
03

Conditions

Emergence agitation (EA)pain

Beyond the preview

Go deeper on NCT03062488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03062488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call